8-K: Solo Brands Receives NYSE Non-Compliance Notice Due to Low Share Price

Solo Brands, Inc. was notified by the New York Stock Exchange (NYSE) that it is not in compliance with continued listing standards because its Class A common stock price fell below $1.00 over a consecutive 30 trading-day period.

Summary

• Solo Brands, Inc. received a notice from the NYSE on February 25, 2025, indicating non-compliance with listing standards.
• The non-compliance stems from the average closing price of the company's Class A common stock falling below $1.00 over the preceding 30 trading days.
• Solo Brands has a six-month cure period to regain compliance, requiring the stock to have a closing price of at least $1.00 and an average closing price of at least $1.00 over the 30 trading-day period ending on the last trading day of any month during the cure period.
• The company intends to respond to the NYSE and may consider a reverse stock split, subject to board and stockholder approval, to address the deficiency.
• The notice does not immediately impact the listing of the Class A common stock, which will continue to trade on the NYSE under the symbol DTC with an added designation of '.BC'.
• The notice does not affect the company's business operations, SEC reporting requirements, or debt obligations.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the non-compliance notice from the NYSE, indicating financial distress and potential risks for investors. However, the company is taking steps to address the issue, which provides some mitigation.

Positives

• The notice has no immediate impact on the listing of Solo Brands' Class A common stock.
• The company has a six-month cure period to regain compliance.
• The notice does not affect the company's ongoing business operations or reporting requirements.
• The notice does not trigger any violation of the company's debt obligations.

Negatives

• Solo Brands' Class A common stock price fell below the NYSE's minimum average closing price requirement of $1.00.
• The company's stock will have an added designation of '.BC' to indicate non-compliance with NYSE listing standards.

Risks

• Failure to regain compliance with the NYSE's minimum share price requirement could lead to delisting.
• A reverse stock split, if implemented, could negatively impact stockholders.
• Negative reactions from employees, vendors, customers, lenders, and investors to the NYSE notice of non-compliance could adversely affect the company.
• Management transitions could impact the company's common stock.

Future Outlook

Solo Brands plans to respond to the NYSE regarding its intent to cure the deficiency, which may include a reverse stock split, subject to board and stockholder approval. The company has six months to regain compliance with the minimum share price requirement.

Industry Context

Many companies, especially smaller-cap ones, face the risk of falling below minimum share price requirements on major exchanges. This often leads to considering measures like reverse stock splits to maintain listing and investor confidence.

Comparison to Industry Standards

• Many companies in similar situations consider reverse stock splits, a common strategy.
• Companies like ContextLogic (Wish) and Party City have faced similar delisting warnings and have taken actions such as reverse stock splits or exploring strategic alternatives.
• The six-month cure period is standard practice for NYSE compliance.

Stakeholder Impact

• Shareholders may experience dilution if a reverse stock split is implemented.
• Employees may be concerned about the company's financial stability.
• Customers and suppliers may be wary of doing business with a company facing financial challenges.
• Lenders may reassess the company's creditworthiness.

Next Steps

• Solo Brands intends to respond to the NYSE regarding its plan to regain compliance.
• The company may seek approval from the Board of Directors and stockholders for a reverse stock split.
• Solo Brands must achieve a closing share price of at least $1.00 and an average closing share price of at least $1.00 over a 30 trading-day period by the end of the cure period to regain compliance.

Key Dates